By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ideon Science and Technology Park
Sölvegatan 41
Lund    S-223 70  Sweden
Phone: 46-46-286-8550 Fax: 46-46-211-0806



Drug Discovery

Company News
BioInvent (BOVNF) And The University of Pennsylvania Enhance Planned Clinical Study With BI-505 9/21/2015 11:36:45 AM
BioInvent (BOVNF) Interim Report 1 January – 30 June 2015 7/22/2015 10:37:45 AM
BioInvent (BOVNF) Progresses Collaboration With Leading U.S. Biotechnology Company 6/17/2015 11:14:05 AM
BioInvent (BOVNF): Management's Shareholding After Completion Of The Rights Issue 6/15/2015 1:29:48 PM
BioInvent (BOVNF) Enters Into Third Research Collaboration With University of Southampton 6/1/2015 11:17:46 AM
BioInvent (BOVNF): BioInvent’s Rights Issue Oversubscribed 5/18/2015 1:24:13 PM
Annual General Meeting In BioInvent (BOVNF) 4/22/2015 11:18:06 AM
BioInvent (BOVNF) Interim Report 1 January – 31 March 2015 4/22/2015 11:10:43 AM
BioInvent (BOVNF): Cancer Cell Publishes Data Highlighting The Potential Of Bioinvent’s BI-1206 To Help Overcome Antibody Drug Resistance In Cancer Therapy 4/14/2015 12:22:13 PM
BioInvent (BOVNF) Confirms Clinical Strategy For BI-505 And Plans To Conduct Phase IIa Trial In Multiple Myeloma Post-Stem Cell Transplant Patients In The U.S. 3/19/2015 11:20:29 AM